Michael Faderl: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia

Srdan Verstovsek, Francis J Giles, Susan O’Brien, Stefan Faderl, Hagop M Kantarjian, Michael J Keating, Maher Albitar

Journal:

Leukemia Research

Year:

2004

Language:

english

File:

PDF, 238 KB

english, 2004

2

Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia

Deborah A. Thomas, Elihu Estey, Francis J. Giles, Stefan Faderl, Jorge Cortes, Michael Keating, Susan O'Brien, Maher Albitar, Hagop Kantarjian

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 78 KB

english, 2003

3

Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia

Thomas, Deborah A., Cortes, Jorge, O'Brien, Susan, Pierce, Sherry, Faderl, Stefan, Albitar, Maher, Hagemeister, Frederick B., Cabanillas, Fernando F., Murphy, Sharon, Keating, Michael J., Kantarjian,

Journal:

Journal of Clinical Oncology

Year:

1999

Language:

english

File:

PDF, 74 KB

english, 1999

4

The prognostic significance of p16INK4a/p14ARF locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia

Stefan Faderl, Hagop M. Kantarjian, Elihu Estey, Taghi Manshouri, Ching-Yang Chan, Abdel Rahman Elsaied, Steven M. Kornblau, Jorge Cortes, Deborah A. Thomas, Sherry Pierce, Michael J. Keating, Zeev Es

Journal:

Year:

2000

Language:

english

File:

PDF, 132 KB

english, 2000

5

Expression of apoptosis proteins in chronic myelogenous leukemia : Associations and significance

Farhad Ravandi, Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, Stefan Faderl, Francis J. Giles, Debbie Thomas, Jorge Cortes, Michael Andreeff, Zeev Estrov, Mary-Beth Rios, Maher Albitar

Journal:

Year:

2001

Language:

english

File:

PDF, 122 KB

english, 2001

6

Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor

Michael A. Thompson, Senait W. Dyson, Stefan Faderl

Journal:

American Journal of Hematology

Year:

2006

Language:

english

File:

PDF, 181 KB

english, 2006

7

Reduction of the Estrogenic Side Effects of the Mammary Tumor-Inhibiting Drug [1,2-Bis(2,6-dichloro-4-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II) by Variation of Ring Substituents

Ronald Gust, Johann Karl, Michael Faderl, Helmut Schönenberger

Journal:

Archiv der Pharmazie

Year:

1995

Language:

english

File:

PDF, 642 KB

english, 1995

8

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome

Jorge Cortes, Hagop Kantarjian, Maher Albitar, Deborah Thomas, Stefan Faderl, Charles Koller, Guillermo Garcia-Manero, Francis Giles, Michael Andreeff, Susan O'Brien, Michael Keating, Elihu Estey

Journal:

Year:

2003

Language:

english

File:

PDF, 102 KB

english, 2003

9

Complete cytogenetic and molecular responses to interferon-α-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis

Hagop M. Kantarjian, Susan O'Brien, Jorge E. Cortes, Jianqin Shan, Francis J. Giles, Mary Beth Rios, Stefan H. Faderl, William G. Wierda, Alessandra Ferrajoli, Srdan Verstovsek, Michael J. Keating, Em

Journal:

Year:

2003

Language:

english

File:

PDF, 122 KB

english, 2003

10

Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia

Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, Jorge Cortes, Stefan Faderl, Francis J. Giles, Michael Keating, Maher Albitar

Journal:

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

11

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

Apostolia Tsimberidou, Elihu Estey, Jorge Cortes, Deborah Thomas, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Michael Keating, Maher Albitar, Susan O'Brien, Hagop Kantarjian, Francis Gil

Journal:

Year:

2003

Language:

english

File:

PDF, 90 KB

english, 2003

12

Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia

Sherif Ibrahim, Iman Jilani, Susan O'Brien, Anna Rogers, Taghi Manshouri, Francis Giles, Stefan Faderl, Deborah Thomas, Hagop Kantarjian, Michael Keating, Maher Albitar

Journal:

Year:

2003

Language:

english

File:

PDF, 532 KB

english, 2003

13

Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Francis J. Giles, Stefan Faderl, Jean-Pierre Issa, Guillermo Garcia-Manero, Mary Beth Rios, Jianqin Shan, Michael Andreeff, Michael Keating, Moshe Tal

Journal:

Year:

2003

Language:

english

File:

PDF, 90 KB

english, 2003

14

Phase II study of alemtuzumab in chronic lymphoproliferative disorders

Alessandra Ferrajoli, Susan M. O'Brien, Jorge E. Cortes, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Razelle Kurzrock, Susan Lerner, Dimitrios P. Kontoyiannis, Michael J. Keating

Journal:

Year:

2003

Language:

english

File:

PDF, 82 KB

english, 2003

15

Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in early chronic phase

Susan O'Brien, Francis Giles, Moshe Talpaz, Jorge Cortes, Mary Beth Rios, Jianqin Shan, Deborah Thomas, Michael Andreeff, Steven Kornblau, Stefan Faderl, Guillermo Garcia-Manero, Kevin White, Susie Ma

Journal:

Year:

2003

Language:

english

File:

PDF, 85 KB

english, 2003

16

The role of clofarabine in hematologic and solid malignancies—Development of a next-generation nucleoside analog

Stefan Faderl, Varsha Gandhi, Michael J. Keating, Sima Jeha, William Plunkett, Hagop M. Kantarjian

Journal:

Year:

2005

Language:

english

File:

PDF, 190 KB

english, 2005

17

Thalidomide therapy for myelofibrosis with myeloid metaplasia

Deborah A. Thomas, Francis J. Giles, Maher Albitar, Jorge E. Cortes, Srdan Verstovsek, Stefan Faderl, Susan M. O'Brien, Guillermo Garcia-Manero, Michael J. Keating, Sherry Pierce, Jerome Zeldis, Hagop

Journal:

Year:

2006

Language:

english

File:

PDF, 299 KB

english, 2006

18

Activity of alemtuzumab in patients with CD52-positive acute leukemia

Raoul Tibes, Michael J. Keating, Alessandra Ferrajoli, William Wierda, Farhad Ravandi, Guillermo Garcia-Manero, Susan O'Brien, Jorge Cortes, Srdan Verstovsek, Mary L. Browning, Stefan Faderl

Journal:

Year:

2006

Language:

english

File:

PDF, 85 KB

english, 2006

19

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

Stefan Faderl, Kanti Rai, John Gribben, John C. Byrd, Ian W. Flinn, Susan O'Brien, Shihong Sheng, Dixie-Lee Esseltine, Michael J. Keating

Journal:

Year:

2006

Language:

english

File:

PDF, 121 KB

english, 2006

20

Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (Campath-1H)-based therapies

Gautam Borthakur, E Lin, Stefan Faderl, Alessandra Ferrajoli, William Wierda, Francis Giles, Mary L. Browning, Hagop Kantarjian, Michael Keating, Susan O'Brien

Journal:

Year:

2007

Language:

english

File:

PDF, 112 KB

english, 2007

21

Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years

Hagop Kantarjian, Susan O'Brien, Jorge Cortes, William Wierda, Stefan Faderl, Guillermo Garcia-Manero, Jean-Pierre Issa, Elihu Estey, Michael Keating, Emil J. Freireich

Journal:

Year:

2008

Language:

english

File:

PDF, 442 KB

english, 2008

22

Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence

Stefan Faderl, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, Michael J. Keating

Journal:

Year:

2010

Language:

english

File:

PDF, 186 KB

english, 2010

23

Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence

Stefan Faderl, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, Michael J. Keating

Journal:

Year:

2010

File:

PDF, 34 KB

2010

24

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia : Long-term follow-up of a phase 2 study

Michael Rytting, Farhad Ravandi, Elihu Estey, Jorge Cortes, Stefan Faderl, Guillermo Garcia-Manero, Sima Jeha, Souzanne Ouzounian, Sherry Pierce, Hagop Kantarjian

Journal:

Year:

2010

Language:

english

File:

PDF, 203 KB

english, 2010

25

Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia

Bang-Ning Lee, Hui Gao, Evan N. Cohen, Xavier Badoux, William G. Wierda, Zeev Estrov, Stefan H. Faderl, Michael J. Keating, Alessandra Ferrajoli, James M. Reuben

Journal:

Year:

2011

Language:

english

File:

PDF, 386 KB

english, 2011

26

Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome

Karen W.L. Yee, Jorge Cortes, Alessandra Ferrajoli, Guillermo Garcia-Manero, Srdan Verstovsek, William Wierda, Deborah Thomas, Stefan Faderl, Ivan King, Susan M. O’Brien, Sima Jeha, Michael Andreeff,

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 143 KB

english, 2006

27

T-cell large granular lymphocytic (T-LGL) leukemia: Experience in a single institution over 8 years

Ahmed Aribi, Yang Huh, Michael Keating, Susan O’Brien, Alessandra Ferrajoli, Stefan Faderl, William Wierda, Hagop Kantarjian, Farhad Ravandi

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 129 KB

english, 2007

28

Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL

Stefan Faderl, William Wierda, Susan O’Brien, Alessandra Ferrajoli, Susan Lerner, Michael J. Keating

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 139 KB

english, 2010

29

Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival

Francis J. Giles, Hagop M. Kantarjian, B. Nebiyou Bekele, Jorge E. Cortes, Stephan Faderl, Deborah A. Thomas, Taghi Manshouri, Anna Rogers, Michael J. Keating, Moshe Talpaz, Susan O'Brien, Maher Albit

Journal:

British Journal of Haematology

Year:

2002

Language:

english

File:

PDF, 257 KB

english, 2002

30

Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia

William G. Wierda, Marcella M. Johnson, Kim-Anh Do, Taghi Manshouri, Amanda Dey, Susan O'Brien, Francis J. Giles, Hagop Kantarjian, Deborah Thomas, Stefan Faderl, Susan Lerner, Michael Keating, Maher

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 143 KB

english, 2003

31

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring

Ronald Gust, Michael Faderl, Helmut Schönenberger

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2000

Language:

english

File:

PDF, 116 KB

english, 2000

32

The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells

Wei-Gang Tong, Zeev Estrov, Yongtao Wang, Susan O’Brien, Stefan Faderl, David M. Harris, Quin Van Pham, Inbal Hazan-Halevy, Zhiming Liu, Patricia Koch, Hagop Kantarjian, Michael J. Keating, Alessandra

Journal:

Investigational New Drugs

Year:

2011

Language:

english

File:

PDF, 285 KB

english, 2011

33

New aspects of the treatment of chronic lymphocytic leukemia

Stefan Faderl, William Wierda, Michael J. Keating

Journal:

Current Hematologic Malignancy Reports

Year:

2006

Language:

english

File:

PDF, 131 KB

english, 2006

34

Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)

Gheath Alatrash, Maher Albitar, Susan O’Brien, Xuemei Wang, Taghi Manshouri, Stefan Faderl, Alessandra Ferrajoli, Jan Burger, Guillermo Garcia-Manero, Hagop M. Kantarjian, Susan Lerner, Michael J. Kea

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 143 KB

english, 2010

35

Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin

Farhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, Stefan Faderl, Marina Konopleva, Tapan Kadia, Mark Brandt, Sherry Pierce, Steven Kornblau, Michael Andreeff, Xuemei Wang, Guillermo Garcia-Manero, Jor

Journal:

Year:

2012

Language:

english

File:

PDF, 954 KB

english, 2012

36

Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia

Alessandra Ferrajoli, William G. Wierda, Ruth LaPushin, Susan M. O’Brien, Stefan Faderl, Mary L. Browning, Michael J. Keating

Journal:

European Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 89 KB

english, 2008

37

Augmented Hyper-CVAD Based on Dose-Intensified Vincristine, Dexamethasone, and Asparaginase in Adult Acute Lymphoblastic Leukemia Salvage Therapy

Stefan Faderl, Deborah Ann Thomas, Susan O'Brien, Farhad Ravandi, Guillermo Garcia-Manero, Gautam Borthakur, Alessandra Ferrajoli, Srdan Verstovsek, Mohamed Ayoubi, Michael Rytting, Jennie Feliu, Hago

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 193 KB

english, 2011

38

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, Elias Jabbour, Partow Kebriaei, Michael Rytting, Sergernne York, Farhad Ravandi, Monica Kwari, Stefan Faderl, Mary Beth Rios, Jorge Cortes, Luis Fa

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 255 KB

english, 2012

39

Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Mathisen, Michael S., Kantarjian, Hagop, Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, Borthakur, Gautam, Cortes, Jorge E., Quintás-Cardama, Alfonso

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2013

Language:

english

File:

PDF, 304 KB

english, 2013

40

Monoclonal antibody combinations in CLL: evolving strategies

Stefan Faderl, Susan O'Brien, Michael J. Keating

Journal:

Best Practice & Research Clinical Haematology

Year:

2006

Language:

english

File:

PDF, 126 KB

english, 2006

41

510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation

Asifa Malik, Carlos Bueso-Ramos, Stefan Faderl, Eli Estey, Susan O'Brien, Michael Fernandez, Martin Nguyen, Charles Koller, Emil Freireich, Miloslav Beran, Sherry Pierce, Jorge Cortes, Hagop Kantarjia

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 153 KB

english, 2011

42

3.19 Disease Characteristics and Response to First Therapy in African American Patients with CLL: the M.D. Anderson Cancer Center Experience

Lorenzo Falchi, Susan Lerner, William G. Wierda, Susan O'Brien, Stefan Faderl, Sara Strom, Lynne Abbruzo, Michael J. Keating, Alessandra Ferrajoli

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 95 KB

english, 2011

43

A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients With Hyperglycemic Acute Lymphoblastic Leukemia

Khanh Vu, Naifa Busaidy, Maria E. Cabanillas, Marina Konopleva, Stefan Faderl, Deborah A. Thomas, Susan O'Brien, Kristine Broglio, Joe Ensor, Carmen Escalante, Michael Andreeff, Hagop Kantarjian, Vict

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2012

Language:

english

File:

PDF, 734 KB

english, 2012

44

Management Guidelines for Use of Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia

Keating, Michael, Coutré, Stephen, Rai, Kanti, Österborg, Anders, Faderl, Stefan, Kennedy, Ben, Kipps, Tom, Bodey, Gerald, Byrd, John C., Rosen, Steven, Dearden, Claire, Dyer, Martin J.S., Hillmen, Pe

Journal:

Clinical Lymphoma

Year:

2004

Language:

english

File:

PDF, 172 KB

english, 2004

45

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Kantarjian, Hagop, Thomas, Deborah, Jorgensen, Jeffrey, Kebriaei, Partow, Jabbour, Elias, Rytting, Michael, York, Sergernne, Ravandi, Farhad, Garris, Rebecca, Kwari, Monica, Faderl, Stefan, Cortes, Jo

Journal:

Year:

2013

Language:

english

File:

PDF, 267 KB

english, 2013

46

Clofarabine: Past, present, and future

Kantarjian, Hagop M., Jeha, Sima, Gandhi, Varsha, Wess, Michael, Faderl, Stefan

Journal:

Leukemia and Lymphoma

Year:

2007

Language:

english

File:

PDF, 431 KB

english, 2007

47

Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin (Daunoxome), and Dexamethasone (HyperCVXD) Regimen in Richter's Syndrome

Dabaja, Bouthaina S., O'brien, Susan M., Kantarjian, Hagop M., Cortes, Jorge E., Thomas, Deborah A., Albitar, Maher, Schlette, Ellen S., Faderl, Stefan, Sarris, Andreas, Keating, Michael J., Giles, Fr

Journal:

Leukemia and Lymphoma

Year:

2001

Language:

english

File:

PDF, 529 KB

english, 2001

48

Bone Marrow (BM) May be More Informative Than Peripheral Blood (PB) to Evaluate Minimal Residual Disease (MRD) During 1st and 2nd Year Follow up After First-line Fludarabine, Cyclophosphamide, and Rituximab (FCR) for Chronic Lymphocytic Leukemia (CLL)

Strati, Paolo, Keating, Michael J., O'Brien, Susan M., Burger, Jan, Ferrajoli, Alessandra, Jain, Nitin, Estrov, Zeev, Jorgensen, Jeffrey, Faderl, Stefan H., Wierda, William G.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2014

Language:

english

File:

PDF, 230 KB

english, 2014

49

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome

Verma, Dushyant, Kantarjian, Hagop, Faderl, Stefan, O'Brien, Susan, Pierce, Sherry, Vu, Khanh, Freireich, Emil, Keating, Michael, Cortes, Jorge, Ravandi, Farhad

Journal:

Leukemia and Lymphoma

Year:

2010

Language:

english

File:

PDF, 207 KB

english, 2010

50

Monoclonal antibodies in chronic lymphocytic leukemia

Ferrajoli, Alessandra, Faderl, Stefan, Keating, Michael J

Journal:

Expert Review of Anticancer Therapy

Year:

2006

Language:

english

File:

PDF, 104 KB

english, 2006